Anticlinically amyopathic dermatomyositis- (C-ADM-) 140/MDA5 autoantibodies have been known to be a specific marker for C-ADM and strongly associated with rapidly progressive ILD with C-ADM [41]. The gene discussed is IFIH1; the disease is dermatomyositis.